Digital phenotyping adherence, feasibility, and tolerability in outpatients with schizophrenia.

ABSTRACT: Digital phenotyping has potential for use as an objective and ecologically valid form of symptom assessment in clinical trials for schizophrenia. However, there are critical methodological factors that must be addressed before digital phenotyping can be used for this purpose. The current study evaluated levels of adherence, feasibility, and tolerability for active (i.e., signal and event contingent ecological momentary assessment surveys) and passive (i.e., geolocation, accelerometry, and ambulatory psychophysiology) digital phenotyping methods recorded from smartphone and smartband devices. Participants included outpatients diagnosed with schizophrenia (SZ: n = 54) and demographically matched healthy controls (CN: n = 55), who completed 6 days of digital phenotyping. Adherence was signifi

SUBMITTER: Raugh IM 

PROVIDER: S-EPMC8192468 | biostudies-literature | 2021 Jun

REPOSITORIES: biostudies-literature